Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Inulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Insulin Resistance 1 Hyperandrogenism 1 Glucose Intolerance 1 Endometrial Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma 1 Anovulation 1 Anastomotic Leak 1 Adenomatous Polyposis Coli 1

Interventions

Cisplatin 55 Carboplatin 48 Paclitaxel 42 pembrolizumab 41 Gemcitabine 28 Pemetrexed 22 Radiotherapy 21 Magnetic Resonance Spectroscopy 20 Radiotherapy, Intensity-Modulated 18 Cetuximab 18 Docetaxel 17 Specimen Handling 16 Nivolumab 16 Fluorouracil 16 Cyclophosphamide 14 durvalumab 13 Bevacizumab 13 Sorafenib 12 Radiation 11 Sunitinib 10 Platinum 10 130-nm albumin-bound paclitaxel 10 1,2-diaminocyclohexaneplatinum II citrate 10 osimertinib 9 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Drug Therapy 8 Capecitabine 8 atezolizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05821751 2023-04-20

PRINCESS

Fondazione del Piemonte per l'Oncologia

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡